Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Oba

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
Kidney International|July 24, 2014
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatmentNorishige Yoshikawa, Koichi Nakanishi, Mayumi Sako, et al.
Journal of Cancer|May 29, 2018
The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)Kazuhiro Nishikawa, Toru Aoyama, Mari S Oba, et al.
Oncology Letters|October 19, 2018
Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PDHiromichi Maeda, Ken-Ichi Okada, Tsutomu Fujii, et al.
Clinical and Experimental Gastroenterology|October 29, 2020
No Significant Effect of Daikenchuto (TJ-100) on Peritoneal IL-9 and IFN-γ Levels After PancreaticoduodenectomyHiromichi Maeda, Ken-Ichi Okada, Tsutomu Fujii, et al.
NPJ Breast Cancer|June 26, 2026
Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTETatsunori Shimoi, Nobuhiro Shibata, Masahiro Kitada, et al.
Neuropsychopharmacology Reports|August 15, 2025
Nonrandomized Allocation of Steroid Therapy in Patients With Fukuyama Congenital Muscular Dystrophy: Study Protocol for a Phase II Clinical TrialTerumi Murakami, Takatoshi Sato, Takami Ishizuka, et al.
Neuropsychopharmacology Reports|February 28, 2026
Persistent Interleukin-1β Elevation in Post-COVID-19 Patients: Findings From a Nationwide Registry Study in JapanNaoki Takamatsu, Hiroki Kimura, Mari S Oba, et al.
Surgery|January 10, 2016
Evaluation of the efficacy of daikenchuto (TJ -100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trialKen-ichi Okada, Manabu Kawai, Seiko Hirono, et al.
Surgical Oncology|October 12, 2020
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer by combining magnetic resonance imaging and core needle biopsyKazutaka Narui, Takashi Ishikawa, Mari S Oba, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 15, 2025
Transforming Growth Factor-β Serum Levels Associated with Social Function in Subjects at Ultra-high Risk for Psychosis: A Multicenter StudyYuji Yamada, Naoko Kishimoto, Hiromi Tagata, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
Kidney International|July 24, 2014
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatmentNorishige Yoshikawa, Koichi Nakanishi, Mayumi Sako, et al.
Journal of Cancer|May 29, 2018
The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)Kazuhiro Nishikawa, Toru Aoyama, Mari S Oba, et al.
Oncology Letters|October 19, 2018
Transition of serum cytokines following pancreaticoduodenectomy: A subsidiary study of JAPAN-PDHiromichi Maeda, Ken-Ichi Okada, Tsutomu Fujii, et al.
Clinical and Experimental Gastroenterology|October 29, 2020
No Significant Effect of Daikenchuto (TJ-100) on Peritoneal IL-9 and IFN-γ Levels After PancreaticoduodenectomyHiromichi Maeda, Ken-Ichi Okada, Tsutomu Fujii, et al.
NPJ Breast Cancer|June 26, 2026
Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTETatsunori Shimoi, Nobuhiro Shibata, Masahiro Kitada, et al.
Neuropsychopharmacology Reports|August 15, 2025
Nonrandomized Allocation of Steroid Therapy in Patients With Fukuyama Congenital Muscular Dystrophy: Study Protocol for a Phase II Clinical TrialTerumi Murakami, Takatoshi Sato, Takami Ishizuka, et al.
Neuropsychopharmacology Reports|February 28, 2026
Persistent Interleukin-1β Elevation in Post-COVID-19 Patients: Findings From a Nationwide Registry Study in JapanNaoki Takamatsu, Hiroki Kimura, Mari S Oba, et al.
Surgery|January 10, 2016
Evaluation of the efficacy of daikenchuto (TJ -100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trialKen-ichi Okada, Manabu Kawai, Seiko Hirono, et al.
Surgical Oncology|October 12, 2020
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer by combining magnetic resonance imaging and core needle biopsyKazutaka Narui, Takashi Ishikawa, Mari S Oba, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|July 15, 2025
Transforming Growth Factor-β Serum Levels Associated with Social Function in Subjects at Ultra-high Risk for Psychosis: A Multicenter StudyYuji Yamada, Naoko Kishimoto, Hiromi Tagata, et al.
Pageof 19